Interim Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Share capital	Contributed surplus.	Contributed surplus - options	Contributed surplus - units.	Deficit	Total
Beginning Balance at Nov. 30, 2020	$ 179,746	$ 122	$ 23,303	$ 1,585	$ (20,945)	$ 183,811
Beginning Balance (Shares) at Nov. 30, 2020	144,137,850
Exercise of options	$ 334		(334)
Exercise of options (Shares)	76,635
Stock-based compensation			2,112	36		2,148
Earnings (Loss) for the period					(4,516)	(4,516)
Ending Balance at Feb. 28, 2021	$ 180,080	122	25,081	1,621	(25,461)	181,443
Ending Balance (Shares) at Feb. 28, 2021	144,214,485
Beginning Balance at Nov. 30, 2021	$ 180,820	122	25,990	1,712	(42,605)	166,039
Beginning Balance (Shares) at Nov. 30, 2021	145,009,811
Exercise of options	$ 50		(32)			18
Exercise of options (Shares)	31,674
Restricted Share Units	$ 650			(650)
Restricted Share Units (Shares)	391,332
Joint venture contribution (Shares)	31,469
Stock-based compensation			864	1,001		1,865
Earnings (Loss) for the period					(5,023)	(5,023)
Ending Balance at Feb. 28, 2022	$ 181,571	$ 122	$ 26,822	$ 2,063	$ (47,628)	162,950
Ending Balance (Shares) at Feb. 28, 2022	145,464,286
Joint venture contribution	$ 51					$ 51